HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction.

Abstract
The precise mechanism of the acantholysis after pemphigus IgGs bind to desmoglein (Dsg) 3 and/or Dsg 1 on the cell surface is as yet unknown. We have previously reported that pemphigus IgG (P-IgG) causes a transient increase in intracellular calcium and inositol 1,4,5-trisphosphate concentration, and subsequent activation of protein kinase C (PKC) in DJM-1 cells, a squamous cell carcinoma line. In order to see whether phosphatidylcholine (PC)-specific phospholipase C (PLC) or phospholipase D (PLD) is involved in the P-IgG-induced signaling process, the production of 1,2-diacylglycerol (DAG) and phosphatidylbutanol (PBut), a potential marker for the determination of PLD activity in the presence of butanol, was determined in DJM-1 cells. A biphasic accumulation of DAG, which consisted of a first transient phase and a second sustained phase, was observed. The second phase of DAG accumulation was profoundly inhibited by pretreatment with D609, a selective inhibitor of PC-PLC, but not by propranolol, an inhibitor of phosphatidate phosphohydrolase. Pemphigus serum after preadsortion of antibodies to Dsg 3 and Dsg 1 with recombinant Dsg 3 and Dsg 1 did not show formation of DAG. PBut was not generated following the addition of P-IgG. In addition, the levels of [3H]phosphocholine, a direct metabolite of PC-PLC, were elevated after the addition of P-IgG. These results suggest that the PC-PLC pathway plays a major role in P-IgG-induced transmembrane signaling by causing prolonged generation of DAG, which may lead to long-term activation of PKC.
AuthorsM Seishima, Y Iwasaki-Bessho, Y Itoh, Y Nozawa, M Amagai, Y Kitajima
JournalArchives of dermatological research (Arch Dermatol Res) Vol. 291 Issue 11 Pg. 606-13 (Nov 1999) ISSN: 0340-3696 [Print] Germany
PMID10638334 (Publication Type: Journal Article)
Chemical References
  • Bridged-Ring Compounds
  • Diglycerides
  • Immunoglobulin G
  • Norbornanes
  • Thiocarbamates
  • Thiones
  • Phosphorylcholine
  • tricyclodecane-9-yl-xanthogenate
  • Protein Kinase C
  • Type C Phospholipases
  • Phospholipase D
  • Phosphatidylinositol Diacylglycerol-Lyase
Topics
  • Bridged-Ring Compounds (pharmacology)
  • Diglycerides (biosynthesis)
  • Humans
  • Immunoglobulin G (pharmacology)
  • Norbornanes
  • Pemphigus (immunology)
  • Phosphatidylinositol Diacylglycerol-Lyase
  • Phospholipase D (physiology)
  • Phosphorylcholine (metabolism)
  • Protein Kinase C (physiology)
  • Signal Transduction
  • Thiocarbamates
  • Thiones (pharmacology)
  • Tumor Cells, Cultured
  • Type C Phospholipases (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: